The Medicines Patent Pool offers a working template: branded manufacturers license patents to generic producers for low- and middle-income markets, receive royalties, and retain high-income-country pricing
Hare KJ, Vilsboll T, Asmar M, Deacon CF, Knop FK, and Holst JJ
Poor transitions lead to unnecessary side effects, potential safety risks, and suboptimal results
This study integrates molecular, biochemical, and pharmacological approaches to elucidate artemisinin resistance mechanisms and explore redox modulators as a strategy to restore artemisinin sensitivity
Most United Healthcare plans do not cover GLP-1 receptor agonists for primary weight management in members without type 2 diabetes, though a growing number of employer-sponsored plans have begun offering limited coverage
Can stress affect glutathione levels